New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 11, 2012
12:40 EDTGEVASynageva BioPharma announces 6 month data from extension study of SBC-102
Synageva BioPharma announced six month results from an ongoing extension study of sebelipase alfa in adults with late onset Lysosomal Acid Lipase, LAL, Deficiency at the American Association for the Study of Liver Diseases, AASLD, annual meeting being held in Boston, MA, November 9-13.
News For GEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
16:48 EDTGEVASynageva sees FY15 operating expenses $280M-$25M
Subscribe for More Information
16:48 EDTGEVASynageva reports Q4 EPS ($1.73), consensus ($1.71)
Subscribe for More Information
February 23, 2015
08:09 EDTGEVASynageva announces FDA accepts accepts BLA filing for Kanuma
Subscribe for More Information
07:22 EDTGEVASunTrust to hold a conference
2015 Biotechnology and Pharmaceutical 1:1 Orphan Drug Day is being held in New York on February 23.
February 18, 2015
07:36 EDTGEVASynageva European Patent issued for treatment of LAL deficiency
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use